Benziodarone

This classification denotes an antiarrhythmic agent with the molecular formula C17H12I2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75CL65GTYR, chemically known as 3,5-diiodo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl ketone but generally known as benziodarone, which bears US NIH Compound Identifier 6237. European Medicines Agency schedules Benziodarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05751MIG. The term BENZIODARONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules benziodarone in its Anatomical Therapeutic Chemical (ATC) Classification. BENZIODARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benziodarone under HS 29329985 and SITC 51569. As of Q4 2014, BENZIODARONE remains the US FDA Preferred Term for this commodity. Benziodarone bears US NLM identifiers UMLS ID C0053185 and NCI Concept Code C74127. SMILES: Ic1cc(C(=O)c2c3c(oc2CC)cccc3)cc(I)c1O.